位置:首页 > 蛋白库 > IFR_MEDSA
IFR_MEDSA
ID   IFR_MEDSA               Reviewed;         318 AA.
AC   P52575;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   03-AUG-2022, entry version 94.
DE   RecName: Full=Isoflavone reductase {ECO:0000303|PubMed:7866024};
DE            Short=IFR {ECO:0000303|PubMed:7866024};
DE            EC=1.3.1.45 {ECO:0000269|PubMed:16600295};
DE   AltName: Full=2'-hydroxyisoflavone reductase {ECO:0000305};
DE   AltName: Full=NADPH:isoflavone oxidoreductase {ECO:0000305};
GN   Name=IFR {ECO:0000303|PubMed:7866024};
OS   Medicago sativa (Alfalfa).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Fabales; Fabaceae; Papilionoideae; 50 kb inversion clade;
OC   NPAAA clade; Hologalegina; IRL clade; Trifolieae; Medicago.
OX   NCBI_TaxID=3879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=cv. Apollo;
RX   PubMed=1912490; DOI=10.1007/bf00037051;
RA   Paiva N.L., Edwards R., Sun Y., Hrazdina G., Dixon R.A.;
RT   "Stress responses in alfalfa (Medicago sativa L.) 11. Molecular cloning and
RT   expression of alfalfa isoflavone reductase, a key enzyme of isoflavonoid
RT   phytoalexin biosynthesis.";
RL   Plant Mol. Biol. 17:653-667(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RX   PubMed=7866024; DOI=10.2307/3869908;
RA   Oommen A., Dixon R.A., Paiva N.L.;
RT   "The elicitor-inducible alfalfa isoflavone reductase promoter confers
RT   different patterns of developmental expression in homologous and
RT   heterologous transgenic plants.";
RL   Plant Cell 6:1789-1803(1994).
RN   [3]
RP   INDUCTION.
RX   PubMed=8274775; DOI=10.1094/mpmi-6-655;
RA   Esnault R., Buffard D., Breda C., Sallaud C., El-Turk J., Kondorosi A.;
RT   "Pathological and molecular characterizations of alfalfa interactions with
RT   compatible and incompatible bacteria, Xanthomonas campestris pv. alfalfae
RT   and Pseudomonas syringae pv. pisi.";
RL   Mol. Plant Microbe Interact. 6:655-664(1993).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 3-318, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITE, BINDING SITES, SUBUNIT, AND
RP   MUTAGENESIS OF GLY-14 AND LYS-144.
RX   PubMed=16600295; DOI=10.1016/j.jmb.2006.03.022;
RA   Wang X., He X., Lin J., Shao H., Chang Z., Dixon R.A.;
RT   "Crystal structure of isoflavone reductase from alfalfa (Medicago sativa
RT   L.).";
RL   J. Mol. Biol. 358:1341-1352(2006).
CC   -!- FUNCTION: Reduces achiral isoflavones to chiral isoflavanones during
CC       the biosynthesis of chiral pterocarpan phytoalexins. The reduction
CC       product is a third isomer, which represents the penultimate
CC       intermediate in the synthesis of the phytoalexin (-)-medicarpin, the
CC       major phytoalexin in Alfalfa. {ECO:0000305|PubMed:1912490}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-vestitone + NADP(+) = 2'-hydroxyformononetin + 2 H(+) +
CC         NADPH; Xref=Rhea:RHEA:22560, ChEBI:CHEBI:15378, ChEBI:CHEBI:16786,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:77687; EC=1.3.1.45;
CC         Evidence={ECO:0000269|PubMed:16600295};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=14.2 uM for 2'-hydroxyformononetin {ECO:0000269|PubMed:16600295};
CC   -!- PATHWAY: Phytoalexin biosynthesis; pterocarpan phytoalexin
CC       biosynthesis. {ECO:0000305}.
CC   -!- INDUCTION: By fungal elicitor (PubMed:7866024). Induced by the
CC       bacterial pathogens Pseudomonas syringae pv pisi and Xanthomonas
CC       campestris pv alfalfae (PubMed:8274775). {ECO:0000269|PubMed:7866024,
CC       ECO:0000269|PubMed:8274775}.
CC   -!- SIMILARITY: Belongs to the NmrA-type oxidoreductase family. Isoflavone
CC       reductase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X58078; CAA41106.1; -; mRNA.
DR   EMBL; U17436; AAC48976.1; -; Genomic_DNA.
DR   PIR; S17744; S17744.
DR   PDB; 2GAS; X-ray; 1.60 A; A/B=3-318.
DR   PDBsum; 2GAS; -.
DR   AlphaFoldDB; P52575; -.
DR   SMR; P52575; -.
DR   BioCyc; MetaCyc:MON-5681; -.
DR   UniPathway; UPA00901; -.
DR   EvolutionaryTrace; P52575; -.
DR   GO; GO:0047526; F:2'-hydroxyisoflavone reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006952; P:defense response; IEA:UniProtKB-KW.
DR   GO; GO:0009807; P:lignan biosynthetic process; IEA:UniProt.
DR   CDD; cd05259; PCBER_SDR_a; 1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR008030; NmrA-like.
DR   InterPro; IPR045312; PCBER-like.
DR   Pfam; PF05368; NmrA; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; NADP; Oxidoreductase; Plant defense.
FT   CHAIN           1..318
FT                   /note="Isoflavone reductase"
FT                   /id="PRO_0000204546"
FT   ACT_SITE        144
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:16600295"
FT   BINDING         11..17
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000305|PubMed:16600295"
FT   BINDING         36
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9LD14"
FT   BINDING         44
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9LD14"
FT   BINDING         148
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9LD14"
FT   MUTAGEN         14
FT                   /note="G->F: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:16600295"
FT   MUTAGEN         144
FT                   /note="K->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:16600295"
FT   CONFLICT        132
FT                   /note="E -> D (in Ref. 1; CAA41106)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        179
FT                   /note="T -> A (in Ref. 1; CAA41106)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        229
FT                   /note="E -> K (in Ref. 1; CAA41106)"
FT                   /evidence="ECO:0000305"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           17..27
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          31..35
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           53..65
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           78..85
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          89..93
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           100..102
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           103..113
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          117..120
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           137..154
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          158..162
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   TURN            167..170
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          184..190
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          195..200
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           202..213
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          221..224
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          231..233
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           234..245
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          250..254
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           256..265
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           270..281
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   TURN            292..294
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   STRAND          295..297
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           298..301
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           310..314
FT                   /evidence="ECO:0007829|PDB:2GAS"
FT   HELIX           315..317
FT                   /evidence="ECO:0007829|PDB:2GAS"
SQ   SEQUENCE   318 AA;  35455 MW;  5E2AF9C8CFB79F17 CRC64;
     MATENKILIL GPTGAIGRHI VWASIKAGNP TYALVRKTPG NVNKPKLITA ANPETKEELI
     DNYQSLGVIL LEGDINDHET LVKAIKQVDI VICAAGRLLI EDQVKIIKAI KEAGNVKKFF
     PSEFGLDVDR HEAVEPVRQV FEEKASIRRV IEAEGVPYTY LCCHAFTGYF LRNLAQLDTT
     DPPRDKVVIL GDGNVKGAYV TEADVGTFTI RAANDPNTLN KAVHIRLPEN YLTQNEVIAL
     WEKKIGKTLE KTYVSEEQVL KDIQESSFPH NYLLALYHSQ QIKGDAVYEI DPAKDIEASE
     AYPDVTYTTA DEYLNQFV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024